Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
How Should Providers Deploy Large Language Models? Experts Weigh In
The use of LLMs in healthcare is still quite new, so health systems want to deploy these tools in the least risky way possible. A panel of experts explained how they think health systems can do this during MedCity's INVEST conference — some of their advice included starting with deployment in nonclinical settings and partnering with incumbent vendors rather than startups.
Which Trends Dominated Hospital M&A Activity Last Year?
M&A activity among health systems picked up last year — key trends included cross-market mega-mergers and academic medical centers expanding their community hospital networks. Despite tough economic conditions, Kaufman Hall experts expect this activity to continue growing in 2023.
Humana names first partners in national value-based care hospital program
The payer's value based care program focused on general acute care hospitals was launched earlier this year to provider higher quality and better integrated care for Humana members.
Why University of Chicago Medicine adopted Vocera’s digital rounding tool
In a phone interview, Sue Murphy, a nurse and the chief experience officer at UChicago Medicine, discussed how the Vocera Care Rounds solution has helped patients' voices be heard at her organization.
Humana and Heritage team up on value-based care for Medicare Advantage patients
Under the terms of the deal, select Humana Medicare Advantage HMO plan and dual-eligible members in Southern and Central California will have in-network access to Heritage Provider Network's facilities and physician practices.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.